Inventing for Life
For more than 125 years, MSD, known as Merck & Co in the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, COVID – 19, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.
MSD in Greece
MSD started operating in Greece in 2010. However, a number of its products were available to Greek patients earlier through its long term collaboration with the pharmaceutical industry VIANEX.
Today, MSD has a big portfolio of products in categories such as oncology, vaccines, diabetes, cardiology, immunology, infectious diseases, antibiotics & anesthesiology.
For more information, visit www.msd.gr and connect with us on Twitter, Facebook, YouTube and LinkedIn.
For more than 125 years, MSD, known as Merck & Co in the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, COVID – 19, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.
MSD in Greece
MSD started operating in Greece in 2010. However, a number of its products were available to Greek patients earlier through its long term collaboration with the pharmaceutical industry VIANEX.
Today, MSD has a big portfolio of products in categories such as oncology, vaccines, diabetes, cardiology, immunology, infectious diseases, antibiotics & anesthesiology.
For more information, visit www.msd.gr and connect with us on Twitter, Facebook, YouTube and LinkedIn.
Back
